Quoi de neuf en thérapeutique dermatologique ?

Therapeutics is our daily tool to advance patient care. Although some may perceive a certain stagnation, the goal of this review was to choose among the hundreds of articles published between January and September 2012 those that seemed to contribute the greatest innovation. It is certainly valuable to observe that all include antibodies, cytokines, or conversely chemokine inhibitors, small regulatory molecules or even cells. This diversity illustrates the vitality of the research in dermatology, which covers fields from inflammatory and autoimmune diseases to vascular and infectious diseases. Beyond these established data, many of the results open useful and original leads for future research.